The highly anticipated financial results for the third quarter of Core Laboratories (NYSE: CLB) are scheduled to be disclosed on Wednesday 23rd October 2024. This important update will be made available after market close, providing investors and market participants with key information regarding the company's financial status.
It appears that the concern is on the verge of revealing their estimated $0.23 profit per share for the quarter, as well as their total revenue of $134.45 million for this specific period, according to financial experts on Wall Street.
The company's earnings report for the corresponding quarter of the previous year showcased a per-share income of $0.22. This notable figure was achieved due to the company's impressive total revenue of $125.34 million recorded during that specific period.
Wall Street analysts have revealed their projections for the company's yearly performance, with a total revenue of $531.51 million. Furthermore, they expect the business to achieve profit of $0.92 per share during the fiscal year.
| Period | EPS Actual |
EPS Growth* |
Revenue Actual |
Revenue Growth* |
|---|---|---|---|---|
| Historical Earnings Insight | ||||
| Q2 2024 | $0.22 | +4.8% | 130.58 M | +2.1% |
| Q1 2024 | $0.19 | 0% | 129.64 M | +1.0% |
| Q4 2023 | $0.19 | -5.0% | 128.21 M | +0.5% |
| Q3 2023 | $0.22 | +22.2% | 125.34 M | -0.5% |
| Q2 2023 | $0.21 | +75.0% | 127.88 M | +5.8% |
| *Growth on year-over-year basis | ||||
CLB has scheduled a conference call on 24th October 2024 at 08:30 AM eastern time to discuss the third quarter financial results and other related information.
Throughout Monday's trading, Core Laboratories (CLB) shares fluctuated between $18.47 and $18.98, with a trading volume of 270.00 thousand shares. The stock ended the regular trading session at $18.63, demonstrating downfall of 0.11 percent.